Colorectal Cancer : An End Stage Disease

The signs and symptoms of colon cancer are diarrhea and constipation that may last more than a few days. Also, cramping or belly pain, weakness, fatigue, and unintended weight loss. A medical professional diagnose the patient by finding something suspicious during a screening exam, if there are signs of colon cancer the doctor will recommend an exam. Some exams that can be done are a CT scan, colonoscopy, and biopsy, there are many more ways to find out if you have colon cancer. A CT scan is a scan "to make detailed cross-sectional images of your body". A colonoscopy "the doctor will look at the entire length of the colon and rectrum with a colonoscope (a thin, flexible, lighted tube with a small camera at the end)." Biopsy test

Colorectal cancer mainly starts at colon or the rectum. They are common in most of the way like features, but they have different treatment. What is the different between colon cancer and rectum cancer? Colon cancer happens first four to five feet of the large intestine and rectal cancer happens in the last few inches of the large intestine where it is connected to anus.

Mr BW was a 74-year-old man who had a fall due to a new onset of seizures, which resulted, to a direct impact of his head on the ground while at home. While at the hospital, MR BW underwent a CT and MRI brain scan and showed a haematoma, which resulted to commencing of the patient on Keppra and Bezodiapenes. Moreover, Mr BW also developed a sudden onset of pleuretic chest pain, which was confirmed by CTPA as a small pleural effusion on the left lungs; while there was also pulmonary embolism on both upper and lower lobes of the left lung. Due to the development of a provoked pulmonary embolism, patient commenced on Clexane injection. In September 2015, an elective open abdominoperineal resection was performed on Mr BW, which resulted to prolonged stay in the hospital due to delayed wound healing.

African Americans carry an uneven share of the cancer load in the United States, having the highest death rate and shortest survival of any racial or ethnic group for most cancers. In this article, I will provide updated data for African Americans on cancer rate, death, survival, and cancer screening. I also estimate the total number of deaths prevented among African Americans as a result of the decline in cancer death rates since the early 1990s.

There are about 35,000 new cases each year in the UK. More than 80% of

There are over 100 types of cancer. One type is called colon cancer, a very common disease in the lower part of the digestive system. Colon cancer is luckily very treatable if caught early, but because it is so common it is the second leading cause of death from cancer. About 140,000 people in the U.S. are diagnosed with colon cancer every year.

In 2000, Eloisa Casas was diagnosed with colon cancer. She went through the stages of surgery, radiation, and chemotherapy and one year later with considered to be cancer free and placed in remission. On July 10, 2001, she was addmitted to the hospital with abdominal pain, as well as a fever and an elevated white blood count, which could indicate a possible infection. Her primary physisian and surgeon, Dr. Garcia-Cantu, consulted infectious disease specialist, Dr. Jelinek, who then prescribed her Maxipime as a general antibiotic and Flagyl as an antibiotic for anaerobic bacteria on July 11.

Bowel cancer is the second leading cancer in Australia with over 90 % of whom over 50 years old (Bowel Cancer Australia, 2014). Every year, over 17,000 people are newly diagnosed with bowel cancer (Cancer Council Australia, 2015). The most common treatment for all stages of bowel cancer is removing the cancer and forming a stoma which may help people to maintain the maximum function of their digest system. Depending on the patient’s situation, the colostomy can be reversed to recover the function of absorb nutrition and exclude metabolites. This paper will review the whole process of a patient who received reversal colostomy from admission to discharge, and explain the symptoms that the patient had post operation.

Dr. Pingpank strongly supports treating peritoneal mesothelioma with cytoreduction surgery followed by heated intraperitoneal chemotherapy (HIPEC), where hot chemotherapy drugs are administered directly into the abdomen.

Colon and rectal cancer develop in the digestive tract, which is also called the gastrointestinal, or GI, tract. The digestive system processes food for energy and rids the body of solid waste matter (fecal matter or stool). Colon cancer and rectal cancer have many features in common. Sometimes they are referred to together as colorectal cancer.

Zhu conducted a study to compare the survival rate of patients with colorectal cancer and were treated with a systemic drug, which was oxaliplatin, and those who were treated with CRS-HIPEC. The study showed that those patients who received systemic chemotherapy had an average survival of 24 months, while those who received CRS-HIPEC had a survival of 63 months.16 Randomised studies and other cohort studies have provided encouraging information on the overall survival in patients who have undergone CRS-HIPEC treatment with or without early postoperative intraperitoneal chemotherapy (EPIC), as compared to those who obtained systemic

Colorectal cancer is the third most common cancer among men and women in the United States, and mutations in the MUTYH gene significantly increase the risk of developing polyps that may evolve into cancer.1,2 Biallelic mutations in the MUTYH gene can lead to MYH-Associated Polyposis (MAP), which causes the growth of dozens to hundreds of polyps, furthering increasing the risk for colon cancer.2 Meanwhile, recent studies have shown that both biallelic and monoallelic mutations can contribute to bladder, ovarian, gastric, hepatobiliary, endometrial, and breast cancer.3 The MUTYH gene itself codes for the MYH glycosylase enzyme, which repairs mistakes in DNA caused by reactive oxygen species.3,4 Also a sign of oxidative stress, the oxidation product, 8-oxo-7,8-dihydro-2-deoxyguanosine (OG), mimics thymine, eventually matching with adenine and resulting in a complete loss of the cytosine-guanine pair.4 MUTYH removes the undamaged A base from the mismatched pair, aiding in the correction of such damage.4 However, when MUTYH is mutated, there is an increase in G to T mutations, which can eventually affect the tumor suppressor genes APC and K-ras and lead to tumor formation.4 The MUTYH variants Y165C and G382D are the most common mutations seen in individuals with MAP, and for this reason are of great interest in research working towards reducing the risk of colorectal cancer.2,4 In recent years, the CRISPR/Cas system for gene editing has become the preferred method for

The patient came to the emergency room complaining that his procedure, which created a new opening in his colon to allow for a damaged section of his colon to be bypassed, failed. The new opening was placed after a tumor caused by colon cancer was removed. Earlier in the day he felt nauseated, however, he denies vomiting blood or the presence of blood in his stool. In addition, he denied having difficulty or pain when swallowing, having pain when he speaks, or spitting up blood. When looking at his musculoskeletal system he denied having joint pain, or inflamed joints. Finally, he denied having pain while urinating or blood in his urine.

The patient is a 69-year-old male who presents to the ED complaining of worsening abdominal pain, nausea, vomiting, unable to tolerate po. The CAT scan done the ED shows multiple hypodense lesions consistent with progressive metastatic disease with some distal gastric wall thickening and colonic wall thickening. The patient also presents with some rectal bleeding, generalized weakness and loss of appetite. The patient is known to have coronary artery disease, had recent stenting back in December with colon cancer with metastases. He has had chemotherapy and tumor embolization with Y 90. He initially tolerated all well with good response to the PET scan but recently has returned progressive metastatic disease in the liver metastases, as

Colorectal cancer mainly starts at colon or the rectum. They are common in most of the way like features, but they have different treatment. What is the different between colon cancer and rectal cancer? Colon cancer happens first four to five feet of the large intestine and rectal cancer happens in the last few inches of the large intestine where it is connected to anus. (cancercenter.com)